Literature DB >> 7640613

Polymyalgia rheumatica and giant cell arteritis. High dose corticosteroids are recommended.

J Ferris, R Lamb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7640613      PMCID： PMC2550518          DOI： 10.1136/bmj.311.7002.455a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects.

Authors:  V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

2.  Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.

Authors:  V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

Review 3.  ABC of rheumatology. Polymyalgia rheumatica and giant cell arteritis.

Authors:  G Pountain; B Hazleman
Journal:  BMJ       Date:  1995-04-22

4.  Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients).

Authors:  G Delecoeuillerie; P Joly; A Cohen de Lara; J B Paolaggi
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103
  4 in total
  3 in total

1.  Polymyalgia rheumatica and giant cell arteritis.

Authors:  A B Myles
Journal:  BMJ       Date:  1995-11-04

2.  Steroid management in giant cell arteritis.

Authors:  C C Chan; M Paine; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

3.  Optimal management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Rodger Charlton
Journal:  Ther Clin Risk Manag       Date:  2012-04-05       Impact factor: 2.423
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.